Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 101002
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101002
Table 1 Baseline characteristics of the patients, n (%)
Variables
Pre-matched corhort
Matched corhort
EFTR, n = 362
SR, n = 211
P value
SMD
EFTR, n = 95
SR, n = 95
P value
SMD
Age (years), mean ± SD58.98 ± 8.1459.07 ± 10.610.9060.01059.79 ± 8.9058.64 ± 9.130.3280.127
Sex0.1240.1401.000< 0.001
    Males123 (34.0)86 (40.8)37 (38.9)37 (38.9)
    Females239 (66.0)125 (59.2)58 (61.1)58 (61.1)
Tumor location< 0.0010.7430.9460.088
    Cardia21 (5.8)5 (2.4)4 (4.2)3 (3.2)
    Fundus208 (57.5)60 (28.4)36 (37.9)37 (38.9)
    Body113 (31.2)100 (47.4)44 (46.3)42 (44.2)
    Antrum20 (5.5)46 (21.8)11 (11.6)13 (13.7)
Growth pattern0.1030.1480.7460.070
    Endophytic276 (76.2)147 (69.7)70 (73.7)67 (70.5)
    Exophytic86 (23.8)64 (30.3)25 (26.3)28 (29.5)
Tumor size (cm), mean ± SD1.73 ± 0.843.08 ± 1.11< 0.0011.3712.57 ± 11.12.62 ± 1.150.7630.044
Modified NIH score< 0.0011.4500.9500.086
    Very low risk284 (78.5)42 (19.9)32 (33.7)34 (35.8)
    Low risk70 (19.3)141 (66.8)55 (57.9)53 (55.8)
    Intermediate risk5 (1.4)18 (8.5)5 (5.3)4 (4.2)
    High risk3 (0.8)10 (4.7)3 (3.2)4 (4.2)